<code id='A67F2B620A'></code><style id='A67F2B620A'></style>
    • <acronym id='A67F2B620A'></acronym>
      <center id='A67F2B620A'><center id='A67F2B620A'><tfoot id='A67F2B620A'></tfoot></center><abbr id='A67F2B620A'><dir id='A67F2B620A'><tfoot id='A67F2B620A'></tfoot><noframes id='A67F2B620A'>

    • <optgroup id='A67F2B620A'><strike id='A67F2B620A'><sup id='A67F2B620A'></sup></strike><code id='A67F2B620A'></code></optgroup>
        1. <b id='A67F2B620A'><label id='A67F2B620A'><select id='A67F2B620A'><dt id='A67F2B620A'><span id='A67F2B620A'></span></dt></select></label></b><u id='A67F2B620A'></u>
          <i id='A67F2B620A'><strike id='A67F2B620A'><tt id='A67F2B620A'><pre id='A67F2B620A'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:comprehensive    Page View:78615
          Judge's gavel
          Legal experts unpacked the pharmaceutical industry's scattershot approach to challenging Medicare's new power to negotiate drug prices. Adobe

          WASHINGTON — The pharmaceutical industry has been filing a lawsuit here, there, and pretty much everywhere.

          Drugmakers lost a two-decade long lobbying fight in Congress last summer when Democrats gave Medicare more power to choose what it pays for prescription drugs. Now, they’re taking their battle to the courts.

          advertisement

          Merck filed suit in the District of Columbia. Bristol Myers Squibb filed in New Jersey. The Chamber of Commerce filed in Ohio. PhRMA filed in Texas. And there’s no reason to believe the barrage of lawsuits will stop anytime soon.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          comprehensive

          Continuity nursing helped my family in our darkest PICU moments
          Continuity nursing helped my family in our darkest PICU moments

          EssayauthorSarahMcCarthycuddleswithherdaughterMolly.CourtesySarahMcCarthyTheventilatoralarmwokemeat3

          read more
          New safety details link Apellis eye drug to rare cases of blindness
          New safety details link Apellis eye drug to rare cases of blindness

          AdobeFiveelderlypeoplehavebeenblindedinoneeyebyaseveresideeffectafterreceivinginjectionsofanewlyappr

          read more
          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more

          Mitch McConnell episode has important public health takeaway

          J.ScottApplewhite/APThehandlingofSenateMinorityLeaderMitchMcConnell’sabruptmedicalissuethisweekisrai